Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RP followed by MPR in Elderly MM
NCT01160107Phase 2Completed
- Sponsor
- Fondazione EMN Italy
- Start
- Jul 2008
- Primary completion
- Aug 2012
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of lenalidomide in multiple myeloma (MM), sponsored by Fondazione EMN Italy. Started Jul 2008; status: completed.
02
Drugs
lenalidomide
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT01160107.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01160107.